Premenopausal breast cancer is often characterized by a more aggressive tumor biology, with a higher likelihood of being hormone receptor-negative and a greater incidence of triple-negative breast cancer (TNBC) [26]. Here, NR4A1 is linked to triple-negative breast carcinoma.